Patents by Inventor Thomas Relander

Thomas Relander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutic composition comprising of HDAC inhibitor and a steroid and the use thereof
    Patent number: 10143697
    Abstract: A pharmaceutical composition comprises a HDAC inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture thereof and a steroid or a pharmaceutically acceptable salt thereof as well use of said pharmaceutical composition for the treatment of cancer as a pretreatment prior to other treatments. Said HDAC inhibitor or steroid may alternatively be administrated separately prior to additional treatments.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: December 4, 2018
    Assignee: VALCURIA AB
    Inventors: Kristina Drott, Thomas Relander
  • PHARMACEUTIC COMPOSITION COMPRISING OF HDAC INHIBITOR AND A STEROID AND THE USE THEREOF
    Publication number: 20160271146
    Abstract: A pharmaceutical composition comprises a HDAC inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture thereof and a steroid or a pharmaceutically acceptable salt thereof as well use of said pharmaceutical composition for the treatment of cancer as a pretreatment prior to other treatments. Said HDAC inhibitor or steroid may alternatively be administrated separately prior to additional treatments.
    Type: Application
    Filed: March 18, 2016
    Publication date: September 22, 2016
    Inventors: Kristina DROTT, Thomas RELANDER
  • A PHARMACEUTICAL COMPOSITION COMPRISING A HDAC INHIBITOR AND A STEROID AND THE USE THEREOF
    Publication number: 20140093565
    Abstract: The invention relates to a pharmaceutical composition comprising a HDAC inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture thereof and a steroid or a pharmaceutically acceptable salt thereof as well use of said pharmaceutical composition for the treatment of cancer as a pretreatment prior to other treatments. Said HDAC inhibitor or steroid may alternatively be administrated separately prior to additional treatments.
    Type: Application
    Filed: March 20, 2012
    Publication date: April 3, 2014
    Applicant: VALCURIA AB
    Inventors: Kristina Drott, Thomas Relander